Maria Andrea Hernández-Castañeda

Maria Andrea Hernández-Castañeda

Auto-generated profile, based on publicly available information

Maria Andrea Hernández-Castañeda

Division of Infectious Disease and Internal Medicine, Department of Medicine, University of Minnesota

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MHMaria Andrea Hernández-Castañeda
Maria Andrea Hernández-Castañeda
KHKatharina Happ
Katharina Happ
FCFilippo Cattalani
Filippo Cattalani
AWAlexandra Wallimann
Alexandra Wallimann
MBMarianne Blanchard
Marianne Blanchard
MWMichael Walch
Michael Walch
Plasmodium spp., the causative agent of malaria, have a complex life cycle. The exponential growth of the parasites during the blood stage is responsible for almost all malaria-associated morbidity and mortality. Therefore, tight immune control of the intraerythrocytic replication of the parasite is essential to prevent clinical malaria. Despite evidence that the particular lymphocyte subset of γδ T cells contributes to protective immunity during the blood stage in naive hosts, their precise inhibitory mechanisms remain unclear. Using human PBMCs, we confirmed in this study that γδ T cells specifically and massively expanded upon activation with Plasmodium falciparum culture supernatant. We also demonstrate that these activated cells gain cytolytic potential by upregulating cytotoxic effector proteins and IFN-γ. The killer cells bound to infected RBCs and killed intracellular P. falciparum via the transfer of the granzymes, which was mediated by granulysin in a stage-specific manner. Several vital plasmodial proteins were efficiently destroyed by granzyme B, suggesting proteolytic degradation of these proteins as essential in the lymphocyte-mediated death pathway. Overall, these data establish a granzyme- and granulysin-mediated innate immune mechanism exerted by γδ T cells to kill late-stage blood-residing P. falciparum. Key Points γδ T cells expand and develop cytolytic potential in response to malaria cultures. γδ T cells inhibit parasite growth in a contact- and granzyme-dependent manner. Granulysin delivers granzyme B into RBCs to kill late-stage parasites.

19 May 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
MHMaria Andrea Hernández-Castañeda
Maria Andrea Hernández-Castañeda
MLMarilyne LAVERGNE
Marilyne LAVERGNE
PCPierina Casanova
Pierina Casanova
BNBryan Nydegger
Bryan Nydegger
CMCarla Merten
Carla Merten
MWMichael Walch
Michael Walch
Malaria remains one of the most serious health problems in developing countries. The causative agent of malaria,Plasmodiumspp., have a complex life cycle involving multiple developmental stages as well as different morphological, biochemical and metabolic requirements. We recently found that γδ T cells control parasite growth using pore-forming proteins to deliver their cytotoxic proteases, the granzymes, into blood residing parasites. Here, we follow up on the molecular mechanisms of parasite growth inhibition by human pore-forming proteins. We confirm thatPlasmodium falciparuminfection efficiently depletes the red blood cells of cholesterol, which renders the parasite surrounding membranes susceptible to lysis by prokaryotic membrane disrupting proteins, such as lymphocytic granulysin or the human cathelicidin LL-37. Interestingly, not the cholesterol depletion but rather the simultaneous exposure of phosphatidylserine, a negatively charged phospholipid, triggers resistance of late stage parasitized red blood cells towards the eukaryotic pore forming protein perforin. Overall, by revealing the molecular events we establish here a pathogen-host interaction that involves host cell membrane remodeling that defines the susceptibility towards cytolytic molecules.

14 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSarah A. McNitt
Sarah A. McNitt
JDJenna K. Dick
Jenna K. Dick
MCMaria Hernandez Castaneda
Maria Hernandez Castaneda
JSJules A. Sangala
Jules A. Sangala
MPMark Pierson
Mark Pierson
GHGeoffrey T. Hart
Geoffrey T. Hart
Plasmodium falciparum infection can trigger high levels of inflammation that lead to fever and sometimes severe disease. People living in malaria-endemic areas gradually develop resistance to symptomatic malaria and control both parasite numbers and the inflammatory response. We previously found that adaptive natural killer (NK) cells correlate with reduced parasite load and protection from symptoms. We also previously found that murine NK cell production of IL-10 can protect mice from experimental cerebral malaria. Human NK cells can also secrete IL-10, but it was unknown what NK cell subsets produce IL-10 and if this is affected by malaria experience. We hypothesize that NK cell immunoregulation may lower inflammation and reduce fever induction. Here, we show that NK cells from subjects with malaria experience make significantly more IL-10 than subjects with no malaria experience. We then determined the proportions of NK cells that are cytotoxic and produce interferon gamma and/or IL-10 and identified a signature of adaptive and checkpoint molecules on IL-10-producing NK cells. Lastly, we find that co-culture with primary monocytes, Plasmodium -infected RBCs, and antibody induces IL-10 production by NK cells. These data suggest that NK cells may contribute to protection from malaria symptoms via IL-10 production.